Skip to content

Benefit of oral colostrum in very preterm infants: A trial

Efficacy of oropharyngeal administration of colostrum in reducing morbidity and mortality in very preterm infants: A randomized controlled trial - Colostrum

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/11/010396
Enrollment
260
Registered
2017-11-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Very premature infants if they meet the following inclusion criteria: gestational age 26-31 completed weeks at birth

Interventions

Intervention1: Colostrum: A measured 0.2 mL of colostrum or placebo will be administered via the oropharyngeal route. Control Intervention1: Sterile water: A measured 0.2 mL of colostrum or placebo wi

Sponsors

JIPMER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Very premature infants if they meet the following inclusion criteria: gestational age 26-31completed weeks at birth; mother plans to provide milk; NICU admission <= 12 hours of life.

Exclusion criteria

Exclusion criteria: Birth asphyxia (cord pH/first hour arterial pH < 7.0 or chest compressions); presence of major congenital anomalies or chromosomal disorders; HIV positive mother; maternal age less than 18 years; maternal drug or substance abuse that precludes infant from receiving motherâ??s milk; suspected inborn error of metabolism; lack of parental consent.

Design outcomes

Primary

MeasureTime frame
Comparison of the effect of oropharyngeal administration of colostrum versus placebo, on(1) a composite of death, late-onset sepsis or necrotizing enterocolitis in the neonatal period.Timepoint: 28 days

Secondary

MeasureTime frame
Incidence of death, necrotizing enterocolitis, late-onset sepsis, clinical sepsis, intraventricular hemorrhage, ventilator-associated pneumonia, retinopathy of prematurity and broncho pulmonary dysplasia; time to full feeds; time to regain birth weight; duration of hospital stay; and survival without major neurosensory impairment at 6 months.Timepoint: 6 months

Countries

India

Contacts

Public ContactRahul Aggarwal

JIPMER, Puducherry

plakkal@gmail.com8505905775

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026